Todd Neale

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Weight regain and worsening cardiometabolic status are real threats. Too few physicians pay notice, a new viewpoint argues.

The latest data show healthy compensation levels and resilience, but the impact of ownership changes remains unclear.

The result calls into question the prospects of FDA approval for the Acurate neo2 valve, which is already in use globally.

The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency energy.

For both civilians and military veterans, war destroys health infrastructure and has profound effects on CV risk factors.

Surviving a SARS-CoV-2 infection may be a reason to be more vigilant about general CV prevention measures moving forward.

With a much longer half-life than other radiotracers, flurpiridaz F-18 will boost patient access to PET imaging, one expert predicts.

Indications that the GLP-1 drug has greater benefits in the most frail patients should be viewed cautiously, one expert says.

The system achieved safety and efficacy goals, likely meeting the threshold for approval, but a few strokes raised concerns.